LEVOFLOXACIN, METRONIDAZOLE, AND LANSOPRAZOLE TRIPLE THERAPY COMPARED TO QUADRUPLE THERAPY AS A SECOND-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION IN KOREA

被引：0
|
作者：
Kim, G. [1 ]
Lee, B. [1 ]
Lee, H. [1 ]
Song, G. [1 ]
Seol, S. [2 ]
机构：
[1] Pusan Natl Univ, Sch Med, Pusan, South Korea
[2] Inje Univ, Coll Med, Pusan, South Korea
来源：
HELICOBACTER | 2013年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：126 / 126
页数：1
相关论文
共 50 条
  • [1] Levofloxacin, Metronidazole, and Lansoprazole Triple Therapy Compared to Quadruple Therapy as a Second-Line Treatment of Helicobacter pylori Infection in Korea
    Moon, Ji Yoon
    Kim, Gwang Ha
    You, Hyun Seok
    Lee, Bong Eun
    Ryu, Dong Yeop
    Cheong, Jae Hoon
    Jung, Jung Im
    Jeong, Jae Hoon
    Song, Chul Soo
    Song, Geun Am
    [J]. GUT AND LIVER, 2013, 7 (04) : 406 - 410
  • [2] Levofloxacin, Metronidazole and Lansoprazole Triple Therapy Compared to Quadruple Therapy as a Second Line Treatment of Helicobacter pylori Infection
    Moon, Ji Yoon
    Kim, Gwang Ha
    Choi, Mun Ki
    Lee, Bong Eun
    Song, Chul Soo
    Song, Geun Am
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S483 - S483
  • [3] Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection
    Wong, WM
    Gu, Q
    Chu, KM
    Yee, YK
    Fung, FMY
    Tong, TSM
    Chan, AOO
    Lai, KC
    Chan, CK
    Wong, BCY
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (03) : 421 - 427
  • [4] Quadruple therapy should be second-line treatment for Helicobacter pylori infection
    Axon, A
    [J]. HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2000, 2000, : 631 - 635
  • [5] Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection
    Wong, WM
    Gu, Q
    Lam, SK
    Fung, FMY
    Lai, KC
    Hu, WHC
    Yee, YK
    Chan, CK
    Xia, HHX
    Yuen, MF
    Wong, BCY
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (04) : 553 - 560
  • [6] Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment:: a randomized trial
    Nista, EC
    Candelli, M
    Cremonini, F
    Cazzato, IA
    Di Caro, S
    Gabrielli, M
    Santarelli, L
    Zocco, MA
    Ojetti, V
    Carloni, E
    Cammarota, G
    Gasbarrini, G
    Gasbarrini, A
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (06) : 627 - 633
  • [7] Levofloxacin Sequential Therapy vs Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori : A Randomized Trial
    Liou, Jyh-Ming
    Bair, Ming-Jong
    Chen, Chieh-Chang
    Lee, Yi-Chia
    Chen, Mei-Jyh
    Chen, Chien-Chuan
    Tseng, Cheng-Hao
    Fang, Yu-Jen
    Lee, Ji-Yuh
    Yang, Tsung-Hua
    Luo, Jiing-Chyuan
    Wu, Jeng-Yih
    Chang, Wen-Hsiung
    Chang, Chun-Chao
    Chen, Chi-Yi
    Chen, Po-Yueh
    Shun, Chia-Tung
    Hsu, Wen-Feng
    Hung, Hsu-Wei
    Lin, Jaw-Town
    Chang, Chi-Yang
    Wu, Ming-Shiang
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (03): : 381 - 387
  • [8] Impact of previous metronidazole exposure on metronidazole-based second-line quadruple therapy for Helicobacter pylori infection
    Lee, Gil Ho
    Lee, Kee Myung
    Shin, Sung Jae
    Kang, Joon Koo
    Noh, Choong-Kyun
    Kim, Jin Hong
    Lim, Sun Gyo
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (05): : 1094 - 1103
  • [9] THE TREND OF ERADICATION RATES OF FIRST LINE THERAPY AND SECOND LINE QUADRUPLE THERAPY CONTAINING METRONIDAZOLE FOR HELICOBACTER PYLORI INFECTION IN KOREA
    Song, J.
    Chung, I.
    [J]. HELICOBACTER, 2011, 16 : 137 - 137
  • [10] Levofloxacin based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy
    Watanabe, Y
    Aoyama, N
    Shirasaka, D
    Maekawa, S
    Kuroda, K
    Miki, I
    Kachi, M
    Fukuda, M
    Wambura, C
    Tamura, T
    Kasuga, M
    [J]. DIGESTIVE AND LIVER DISEASE, 2003, 35 (10) : 711 - 715
12345